Target intelligence / Profile preview

Ceruloplasmin pseudogene (CPP)

Target
CPP
Molecular classification
Pseudogene
01

Overview

Ceruloplasmin pseudogene (CPP) refers to a genomic DNA sequence that closely resembles the functional ceruloplasmin (*CP*) gene but is considered non-functional due to mutations such as frameshifts or premature stop codons that preclude the production of an active protein product[3][4]. The CPP pseudogene shares high sequence homology (97%) with the wild-type *CP* gene, but contains deletions and duplications resulting in an inability to encode a functional protein, and there is no detectable transcript corresponding to this pseudogene in human liver[3]. While a few pseudogenes have emerging regulatory or RNA-level functions in the genome, there is currently no evidence that ceruloplasmin pseudogene has a known biological or therapeutic role, is involved in disease, or is a target for any approved or investigational drugs[3][4][7]. Explanation and considerations: - **Is_target:** False: Pseudogenes do not encode functional proteins and are not direct targets for drugs or therapies in the conventional sense[4][7]. - **Is_incorrect:** True: The query refers to a pseudogene as a therapeutic target, which is not applicable. "Ceruloplasmin pseudogene" is not considered a valid drug target, receptor, enzyme, transporter, or other functional biomolecule. - **Molecular_classifications:** Pseudogene is the only applicable category; it does not fit into classic target families like receptor, enzyme, or transporter. - **Biological functions, disease roles, interacting drugs, mechanisms of action, biomarkers, and safety concerns:** There is no established function or clinical significance for this pseudogene; standard annotations in these fields do not apply[3][4][7]. - **Aliases:** As a pseudogene, its main aliases are the formal gene designation ("CPP") and descriptive term ("ceruloplasmin pseudogene"). - **Description:** Clearly delineates it is a processed, non-functional copy, with no demonstrated functional relevance as a drug or biomarker target, and distinguishes it from the functional ceruloplasmin gene and protein[3][4].

Other names
Ceruloplasmin pseudogeneCPP

Beyond the preview

Go deeper on Ceruloplasmin pseudogene (CPP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceruloplasmin pseudogene (CPP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call